Phage therapy 101

REGISTER HERE in person & online registration options - this link will take you to the ticketing site Humanitix

PROGRAM NOW AVAILABLE please be aware that the program can change at anytime without notice

Program committee
Prof Jon Iredell Senior Staff Specialist Westmead Hospital, Director Centre for Infectious Diseases and Microbiology, Westmead Institute for Medical Research, Professor of Medicine and Microbiology, University of Sydney
Dr Holly Sinclair Advanced Therapeutics Fellow, Westmead Hospital
A/Prof Ameneh Khatami Paediatric Infectious Diseases Specialist, Westmead Children’s Hospital, Associate Professor, Discipline of Child and Adolescent Health, Children's Hospital at Westmead Clinical School

This practically oriented one-day course is designed for those prescribing bacteriophage therapy or considering doing so. Sessions will cover diagnostics (with a strong emphasis on genomics), quality assurance and batch production assessments and dispensing, clinical trial and regulatory aspects, current experience in regard to pharmacokinetics and pharmacodynamics, clinical experience with phage therapy in humans and the co-adaptation of phages and bacteria in vivo.

The course is designed to support doctors, nurses and pharmacists by providing the necessary knowledge base for safe delivery of therapeutic phages. The faculty includes clinicians with extensive hands-on experience in adult and paediatric medicine and will be delivered on line and in person at Westmead.

Confirmed Speakers include;
Prof Robert Edwards, Matthew Flinders Fellow in Bioinformatics at Flinders University, Adelaide SA
Prof Morgyn Warner, Clinical Director of Microbiology and Infectious Diseases at SA Pathology
Dr Kerry Watts, Senior Project and Policy Officer, Advanced Therapeutics, Office for Health and Medical Research (MoH)
Please check out the program above for a comprehensive list of esteemed speakers presenting at the course

Sessions will include;
Biology & Biotech 
Basic PK/PD, receptors, defences and adaptations 
From diagnostics to production QC 
High-throughput genomics for advanced therapeutics 
Practical bioinformatics for phage therapy 

Delivering phage therapy 
Health Economics/ SROI 
Biobanking and GMP 
NSW pharmacy and TGA guidelines 
Handling GMO phages: a Pharmacy perspective 
Phage delivery at home and in hospital 
Inflammatory responses 

Clinical experience 
Current experience, including QAMH, STAMP 
staph aureus: ABSA01, diSArm 
pseudomonal infection, incl. CF and non-CF 
Case 4: (CM42) in vivo evolution 
STAMP 2.0, SABRE Phi and future trials